Approval · Notice of Compliance 4961 · 1995
CEDAX: Notice of Compliance 4961
Issued May 9, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4961
- Date
- May 9, 1995
- Company
- Schering Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEDAX | 02165465 | — |
| CEDAX | 02165473 | — |
| CEDAX | 02165449 | — |
| CEDAX | 02165457 | — |
Medicinal ingredients
- CEFTIBUTEN 200 MG per CAP
- CEFTIBUTEN 400 MG per CAP
- CEFTIBUTEN 90 MG per 5ML
- CEFTIBUTEN 180 MG per 5ML